Ligand validation:4XK8

HTG: heptyl 1-thio-beta-D-glucopyranoside

HTG is a Ligand Of Interest in 4XK8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XK8_HTG_A_855	65%	56%	0.156	0.959	1.03	0.69	2	-	0	0	100%	1
4XK8_HTG_a_857	34%	59%	0.244	0.931	1.05	0.55	2	-	0	0	100%	1
4XK8_HTG_J_3001	30%	59%	0.187	0.852	1.05	0.53	2	-	0	0	100%	1
4XK8_HTG_j_3001	14%	56%	0.366	0.924	1.11	0.59	2	-	0	0	100%	1
4XK8_HTG_F_302	12%	58%	0.314	0.843	1.01	0.61	2	-	0	0	100%	1
4XK8_HTG_f_7001	12%	58%	0.333	0.861	1.05	0.58	2	-	0	0	100%	1
7DKZ_HTG_A_854	78%	54%	0.104	0.946	0.84	0.92	1	-	0	0	100%	1
3EJD_HTG_A_100	98%	9%	0.031	0.991	3.37	1.11	2	1	0	0	79%	0.7895
3EJE_HTG_A_100	97%	9%	0.036	0.986	3.34	1.2	2	1	0	0	79%	0.7895
2HPY_HTG_A_1508	94%	7%	0.068	0.968	2.48	2.29	8	2	1	0	100%	1
5V2C_HTG_O_303	94%	33%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	40%	0.092	0.971	1.13	1.22	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.